Biotechnology and the pharmaceutical industry.
作者信息
Rubin S
机构信息
United States Congress Office of Technology Assessment, Washington, D.C. 20510.
出版信息
Cancer Invest. 1993;11(4):451-7. doi: 10.3109/07357909309018876.
PMID:8324649
Abstract
摘要
相似文献
1
Biotechnology and the pharmaceutical industry.
Cancer Invest. 1993;11(4):451-7. doi: 10.3109/07357909309018876.
2
Biotechnology partnerships--medicine for an ailing industry?生物技术合作关系——拯救困境行业的良药？
Nat Biotechnol. 2003 Aug;21(8):847-8. doi: 10.1038/nbt0803-847.
3
Deal watch: Trends in platform technology deal-making.交易观察：平台技术交易的趋势
Nat Rev Drug Discov. 2009 Dec;8(12):923. doi: 10.1038/nrd3065.
4
Biotech on the brink.生物技术处于危机边缘。
Hosp Health Netw. 1993 Sep 5;67(17):36, 38.
5
Prescription for an ailing pharmaceutical industry.给陷入困境的制药行业的药方。
Nat Biotechnol. 2002 Apr;20(4):331. doi: 10.1038/nbt0402-331.
6
Into the 21st century. Biotechnology and the pharmaceutical industry in the next ten years.进入21世纪。未来十年的生物技术与制药行业。
Biotechnology (N Y). 1993 Mar;11(3):S16-20. doi: 10.1038/nbt0393-s16.
7
The next decade of biotechnology--where are we going?生物技术的下一个十年——我们将何去何从？
J Parenter Sci Technol. 1990 Mar-Apr;44(2):66-73.
8
Biotechnology discovery productivity: a note of caution.生物技术发现的生产力：一则警示
Drug Discov Today. 2003 Nov 1;8(21):973-4. doi: 10.1016/s1359-6446(03)02840-x.
9
Private company profiles.私人公司简介。
Nat Biotechnol. 2003 Jul;21 Suppl:BE23-8.
10
Advancing in the face of conventional wisdom.逆势前行。
Drug Discov Today. 2004 Feb 1;9(3):110-1. doi: 10.1016/S1359-6446(03)02947-7.
Zotero 插件